Thomas Laur, DNAnexus | theCUBE + NYSE Wired: MedTech Unplugged скачать в хорошем качестве

Thomas Laur, DNAnexus | theCUBE + NYSE Wired: MedTech Unplugged

In this interview from the theCUBE + NYSE Wired: MedTech Unplugged: The Future of AI in Healthcare & Life Sciences event, Thomas Laur, chief executive officer of DNAnexus, joins theCUBE’s John Furrier to explain why “omics” is becoming a core data object in modern care – and why the hard part is not novelty, but execution. Laur describes DNAnexus as a secure, compliant cloud platform built for multiomics at scale, where organizations can ingest multimodal data, normalize it, collaborate with controlled access and audit trails, and run increasingly sophisticated algorithms to extract clinical and scientific insight. The conversation zeroes in on the shift from promise to proof: what it takes to make precision medicine operational across drug discovery, regulatory approval and the point of care. Laur argues that AI’s upside in healthcare depends on more organized, omics-enabled data – and on infrastructure that can meet governance, sovereignty and quality-system demands without slowing progress. He also frames the “N plus one” future as hyper-personalized medicine, moving therapy from trial-and-error toward prediction, with oncology as the proving ground. Find more SiliconANGLE news and analysis https://siliconangle.com/ Follow theCUBE's wall-to-wall event coverage https://siliconangle.com/events/ Learn about the latest theCUBE events https://www.thecube.net/ 00:00 - Intro 00:06 - Unveiling DNAnexus: A Journey into AI and Innovation 02:57 - Evolution of Technology in Healthcare 05:40 - The Omics Revolution 08:23 - Applications of Omics Beyond Medicine 12:24 - AI Revolution in Healthcare 14:26 - Challenges and Opportunities in AI Data 18:06 - Collaboration and Innovation in AI 20:34 - Revolutionary Impact and Future Perspectives #theCUBE #NYSEWired #MedTechUnplugged #theCUBEresearch #DNAnexus #AIinHealthcare #PrecisionMedicine